Skip to main content
Premium Trial:

Request an Annual Quote

UK Sequencing Provider Buys Illumina Platforms

NEW YORK (GenomeWeb News) – Medical Solutions, a Nottingham, UK-based provider of DNA sequencing and genotyping services, this week announced that it has purchased Illumina’s next-generation sequencing instrument, the Genome Analyzer, and its BeadStation for whole-genome genotyping.
 
According to the firm, it is the first commercial service provider of those platforms in the UK.
 
“Customers have already expressed significant interest in applications run on the Genome Analyzer and BeadStation platforms, and it is our intention to develop strategic partnerships with these early adopters,” Tom Weaver, commercial director of Medical Solutions, said in a statement.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.